Kather H, Simon B
Klin Wochenschr. 1978 Jul 1;56(13):635-9. doi: 10.1007/BF01477016.
The molecular aspects of catecholamine-receptor interactions are reviewed with respect to their clinical implications. Beta- and in some tissues alpha-adrenergic receptors are coupled to the membrane-bound adenylate cyclase. The adrenergic receptor sites are distinct membrane constituents. Their number and the ratio alpha-to beta-receptor site depend on the plasma concentration of catecholamines and are affected by diet and endocrinological factors. Recent clinical studies suggest that long-term treatment with beta-adrenergic agonists may induces desensitization of target tissues due to changes in the adrenergic receptor moieties.
本文就儿茶酚胺 - 受体相互作用的分子层面及其临床意义进行综述。β - 肾上腺素能受体以及在某些组织中的α - 肾上腺素能受体与膜结合型腺苷酸环化酶相偶联。肾上腺素能受体位点是独特的膜成分。它们的数量以及α - 受体位点与β - 受体位点的比例取决于儿茶酚胺的血浆浓度,并受饮食和内分泌因素影响。近期临床研究表明,长期使用β - 肾上腺素能激动剂治疗可能会因肾上腺素能受体部分的变化而导致靶组织脱敏。